Lonidamine

TargetMol
Product Code: TAR-T0239
Supplier: TargetMol
CodeSizePrice
TAR-T0239-2mg2mg£97.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-5mg5mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-10mg10mg£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-25mg25mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-50mg50mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-100mg100mg£193.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0239-500mg500mg£370.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Lonidamine is an indazole carboxylic acid derivative, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK).
CAS:
50264-69-2
Formula:
C15H10Cl2N2O2
Molecular Weight:
321.16
Pathway:
Apoptosis; Metabolism
Purity:
0.9736
SMILES:
OC(=O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12
Target:
Apoptosis; Hexokinase; Mitochondrial Metabolism

References

1. Floridi A, et al. J Natl Cancer Inst, 1981, 66(3), 497-499. 2. Belzacq AS, et al. Oncogene, 2001, 20(52), 7579-7587. 3. Ravagnan L, et al. Oncogene, 1999, 18(16), 2537-2546. 4. Del Bufalo D, et al. J Clin Invest, 1996, 98(5), 1165-1173. 5. Miccoli L, et al. J Natl Cancer Inst, 1998, 90(18), 1400-1406. 6. Guo L, et al. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine. J Biol Chem. 2016 Jan 1;291(1):42-57. 7. Nancolas B, et al. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters. Biochem J. 2016 Apr 1;473(7):929-36.